In continuation of our earlier letter dated June 26, 2025 under subject ''Closure of Trading Window'' under SEBI (Prohibition of Insider Trading ) Regulations, 2015 and Company''s Code of Conduct for Prevention of Insider Trading, the trading window for trading in the securities of the Company shall remain close till August 2, 2025.

pdf

Mankind Pharma Ltd.

14 Jul 2025

2550.60

-0.71%

Corp. Action

Mankind Pharma Ltd - 543904 - Corporate Action-Board to consider Dividend

BSE India

The Board of Directors of the Company, in its meeting scheduled to be held on July 31, 2025 may consider and declare interim dividend for FY 2025-26.

pdf

Mankind Pharma Ltd.

14 Jul 2025

2550.60

-0.71%

Board Meeting

Mankind Pharma Ltd - 543904 - Board Meeting Intimation for Unaudited Quarterly Financial Results & Interim …

BSE India

Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 & 50 of the Listing Regulations, we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, July 31, 2025, inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30, 2025; and declaration of interim dividend, if any, for the financial year 2025-26.

pdf

Mankind Pharma Ltd.

11 Jul 2025

2550.60

-0.71%

Mankind Pharma Gets Target Price Hike Why Jefferies Calls It Top Pick

NDTV Profit

Jefferies anticipates that the first and second quarters will be pivotal for Mankind Pharma, with India Rx growth normalising in the second half of the fiscal.

Mankind Pharma Ltd. has an average target of 2840.50 from 2 brokers.

Stock Market Live Updates 11 July 2025: Stock to buy today: Mankind Pharma

Business Line | 11 Jul 2025 2 more

Mankind Pharma Ltd.

04 Jul 2025, 03:42PM

2550.60

-0.71%

Company Update

Mankind Pharma Ltd - 543904 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018